Raymond James & Associates’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.34M | Sell |
161,380
-745
| -0.5% | -$6.2K | ﹤0.01% | 2481 |
|
|
2024
Q2 | $1.03M | Sell |
162,125
-2,963
| -2% | -$18.8K | ﹤0.01% | 2593 |
|
|
2024
Q1 | $1M | Buy |
165,088
+3,451
| +2% | +$20.9K | ﹤0.01% | 2579 |
|
|
2023
Q4 | $981K | Sell |
161,637
-19,750
| -11% | -$120K | ﹤0.01% | 2521 |
|
|
2023
Q3 | $765K | Buy |
181,387
+20,000
| +12% | +$84.4K | ﹤0.01% | 2613 |
|
|
2023
Q2 | $500K | Hold |
161,387
| – | – | ﹤0.01% | 2923 |
|
|
2023
Q1 | $224K | Hold |
161,387
| – | – | ﹤0.01% | 3399 |
|
|
2022
Q4 | $321K | Hold |
161,387
| – | – | ﹤0.01% | 3158 |
|
|
2022
Q3 | $326K | Sell |
161,387
-4,586
| -3% | -$9.26K | ﹤0.01% | 3115 |
|
|
2022
Q2 | $528K | Sell |
165,973
-2,000
| -1% | -$6.36K | ﹤0.01% | 2872 |
|
|
2022
Q1 | $700K | Sell |
167,973
-4,500
| -3% | -$18.8K | ﹤0.01% | 2836 |
|
|
2021
Q4 | $826K | Sell |
172,473
-2,579
| -1% | -$12.4K | ﹤0.01% | 2746 |
|
|
2021
Q3 | $935K | Buy |
175,052
+2,000
| +1% | +$10.7K | ﹤0.01% | 2619 |
|
|
2021
Q2 | $886K | Buy |
173,052
+3,000
| +2% | +$15.4K | ﹤0.01% | 2669 |
|
|
2021
Q1 | $1.14M | Sell |
170,052
-3,967
| -2% | -$26.7K | ﹤0.01% | 2410 |
|
|
2020
Q4 | $795K | Sell |
174,019
-210
| -0.1% | -$959 | ﹤0.01% | 2480 |
|
|
2020
Q3 | $676K | Buy |
174,229
+6,465
| +4% | +$25.1K | ﹤0.01% | 2421 |
|
|
2020
Q2 | $799K | Buy |
167,764
+250
| +0.1% | +$1.19K | ﹤0.01% | 2302 |
|
|
2020
Q1 | $583K | Buy |
167,514
+37,000
| +28% | +$129K | ﹤0.01% | 2308 |
|
|
2019
Q4 | $629K | Buy |
130,514
+32,880
| +34% | +$158K | ﹤0.01% | 2552 |
|
|
2019
Q3 | $283K | Buy |
97,634
+53,941
| +123% | +$156K | ﹤0.01% | 3025 |
|
|
2019
Q2 | $313K | Buy |
43,693
+5,799
| +15% | +$41.5K | ﹤0.01% | 2970 |
|
|
2019
Q1 | $537K | Sell |
37,894
-9,041
| -19% | -$128K | ﹤0.01% | 2596 |
|
|
2018
Q4 | $635K | Sell |
46,935
-11,860
| -20% | -$160K | ﹤0.01% | 2381 |
|
|
2018
Q3 | $1.31M | Buy |
58,795
+14,834
| +34% | +$329K | ﹤0.01% | 2072 |
|
|
2018
Q2 | $721K | Buy |
+43,961
| New | +$721K | ﹤0.01% | 2421 |
|